NCT05237934View on ClinicalTrials.gov

Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)

RecruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

April 25, 2022

Primary Completion Date

December 31, 2032

Study Completion Date

December 31, 2032

Conditions

Neuroendocrine TumorsCarcinoma, Neuroendocrine

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH